The Gallup survey found that 66 percent of patients who switched from brand-name to compounded GLP-1 versions cited cost as the primary reason, and 34 percent cited insurance coverage problems
Ozempic and similar GLP-1 drugs produce rapid weight loss but come with well-documented trade-offs: nausea in up to 40% of patients and significant muscle mass reduction
But how exactly does this happen
Summary GLP-1 and dual GLP-1/GIP RAs are effective treatments for overweight, obesity, and adiposity-based chronic diseases
doi:10.1038/s41598-019-46045-7
In the following review article, we aim at reviewing the evidence related to the impact of GLP-1 RAs, on gastrointestinal procedures, mainly EGDs and colonoscopies, and their implications on the peri-operative period